Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver.

Berglund ED, Lustig DG, Baheza RA, Hasenour CM, Lee-Young RS, Donahue EP, Lynes SE, Swift LL, Charron MJ, Damon BM, Wasserman DH.

Open source

DOI: 10.2337/db11-0455
Published: 2011-09-01
Container: Diabetes
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2337/db11-0455,
  title = {Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver.},
  author = {Berglund ED and  Lustig DG and  Baheza RA and  Hasenour CM and  Lee-Young RS and  Donahue EP and  Lynes SE and  Swift LL and  Charron MJ and  Damon BM and  Wasserman DH.},
  year = {2011},
  journal = {Diabetes},
  doi = {10.2337/db11-0455},
  url = {https://doi.org/10.2337/db11-0455}
}

RIS

TY  - JOUR
TI  - Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver.
AU  - Berglund ED
AU  -  Lustig DG
AU  -  Baheza RA
AU  -  Hasenour CM
AU  -  Lee-Young RS
AU  -  Donahue EP
AU  -  Lynes SE
AU  -  Swift LL
AU  -  Charron MJ
AU  -  Damon BM
AU  -  Wasserman DH.
PY  - 2011
JO  - Diabetes
DO  - 10.2337/db11-0455
UR  - https://doi.org/10.2337/db11-0455
ER  -

APA

ED, B., DG, L., RA, B., CM, H., RS, L., EP, D., SE, L., LL, S., MJ, C., BM, D., & DH., W. (2011). Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver.. Diabetes. https://doi.org/10.2337/db11-0455

Source records

europe-pmc · retrieved 2026-09-24T22:45:44.268Z